Hospital Corporation of China Limited provided earnings guidance for the six months ended June 30, 2020. For the period, the company expects record a net loss for the Current Period with a range from approximately RMB 520 million to RMB 620 million, as compared to the net profit of approximately RMB 94.9 million for the six months ended June 30, 2019 and (b) record a net loss attributable to owners of the Company for the Current Period with a range from approximately RMB 490 million to RMB 590 million, as compared to the net profit attributable to owners of the Company of approximately RMB 82.0 million for the Corresponding Period; the loss for the Current Period is primarily attributable to the outbreak of Coronavirus Disease 2019 and the instability of macroeconomic environment, which is expected to have negative impact on the financial performance of the Group and lead to impairment losses on relevant intangible assets and goodwill. Impairment losses are one-off non-cash items recorded during the Current Period, which have no direct impact on the cash flow of the Group; and as currently the Coronavirus Disease 2019 situation is becoming stable within the PRC, the impact of Coronavirus Disease 2019 on the business of the Group is overall controllable. The operating business performance of the hospitals owned or managed by the Group is gradually recovering. The financial and cash flow situations of the Group are stable.